AT9283

AT9283 is an inhibitor of JAK2 and AURKA used in studies of JAK-STAT Signaling and Cell Cycle Regulation. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to cytokine-responsive transcriptional signaling and immune regulation and checkpoint control, mitotic progression, and proliferation timing in cancer, cell cycle, and cell signaling models.

By inhibiting JAK2 and AURKA, AT9283 can be used to examine cytokine-responsive transcriptional signaling and immune regulation and checkpoint control, mitotic progression, and proliferation timing. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell cycle, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving JAK2 and AURKA
• Pathway perturbation studies connected to JAK-STAT Signaling and Cell Cycle Regulation
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, AT9283 is appropriate when a defined chemical perturbant is needed to connect JAK2 and AURKA with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell cycle, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.